24-Hydroxylase in cancer: Impact on vitamin D-based anticancer therapeutics

▸ An overview is presented on the role of 24-hydroxylase or CYP24 in cancer. ▸ CYP24 is overexpressed in cancer. ▸ CYP24 could improve or enhance the effectiveness of vitamin D therapeutics. ▸ The role of CYP24 inhibitors in cancer has not been explored.